· Shares of Xerox Corp. (XRX - Free Report) surged 5.8% after reporting adjusted second quarter earnings of $0.87 per share, which beat the Zacks Consensus Estimate of $0.84
· Shares of Archer Daniels Midland Co. (ADM - Free Report) increased 2.7% after reporting second quarter adjusted earnings of $0.57 per share, which soared about 39% year over year, surpassing the Zacks Consensus Estimate of $0.52
· Shares of Royal Caribbean Cruise Ltd. (RCL - Free Report) rose 3.4% after reporting second quarter adjusted earnings of $1.71 per share were 2.4% ahead of the Zacks Consensus Estimate of $1.67
· Shares of Pfizer, Inc. (PFE - Free Report) fell 0.2% after reporting second quarter revenues of $12.90 billion, which fell short of the Zacks Consensus Estimate of $13.02 billion
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
· Shares of Xerox Corp. (XRX - Free Report) surged 5.8% after reporting adjusted second quarter earnings of $0.87 per share, which beat the Zacks Consensus Estimate of $0.84
· Shares of Archer Daniels Midland Co. (ADM - Free Report) increased 2.7% after reporting second quarter adjusted earnings of $0.57 per share, which soared about 39% year over year, surpassing the Zacks Consensus Estimate of $0.52
· Shares of Royal Caribbean Cruise Ltd. (RCL - Free Report) rose 3.4% after reporting second quarter adjusted earnings of $1.71 per share were 2.4% ahead of the Zacks Consensus Estimate of $1.67
· Shares of Pfizer, Inc. (PFE - Free Report) fell 0.2% after reporting second quarter revenues of $12.90 billion, which fell short of the Zacks Consensus Estimate of $13.02 billion
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on PFE - FREE
Get the latest research report on RCL - FREE
Get the latest research report on XRX - FREE
Get the latest research report on ADM - FREE